BR9609911A - Compostos sendo novas n-heterociclil-1-ariloxialquil-4-piperdinaminas processo de preparação de compostos químicos e composições farmacêuticas - Google Patents
Compostos sendo novas n-heterociclil-1-ariloxialquil-4-piperdinaminas processo de preparação de compostos químicos e composições farmacêuticasInfo
- Publication number
- BR9609911A BR9609911A BR9609911A BR9609911A BR9609911A BR 9609911 A BR9609911 A BR 9609911A BR 9609911 A BR9609911 A BR 9609911A BR 9609911 A BR9609911 A BR 9609911A BR 9609911 A BR9609911 A BR 9609911A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- pct
- aryloxyalkyl
- heterocyclyl
- optionally branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9509079A FR2737207B1 (fr) | 1995-07-26 | 1995-07-26 | Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique |
| PCT/FR1996/001176 WO1997005134A1 (fr) | 1995-07-26 | 1996-07-25 | Composes heterocycliques pour le traitement de l'ischemie myocardique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9609911A true BR9609911A (pt) | 1999-03-02 |
Family
ID=9481394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9609911A BR9609911A (pt) | 1995-07-26 | 1996-07-25 | Compostos sendo novas n-heterociclil-1-ariloxialquil-4-piperdinaminas processo de preparação de compostos químicos e composições farmacêuticas |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6011032A (pt) |
| EP (1) | EP0842174B1 (pt) |
| JP (1) | JPH11509857A (pt) |
| KR (1) | KR19990035986A (pt) |
| CN (1) | CN1103338C (pt) |
| AT (1) | ATE206423T1 (pt) |
| AU (1) | AU707950B2 (pt) |
| BR (1) | BR9609911A (pt) |
| CA (1) | CA2228691A1 (pt) |
| DE (1) | DE69615696T2 (pt) |
| DK (1) | DK0842174T3 (pt) |
| ES (1) | ES2165514T3 (pt) |
| FR (1) | FR2737207B1 (pt) |
| MX (1) | MX9800705A (pt) |
| NZ (1) | NZ315347A (pt) |
| PT (1) | PT842174E (pt) |
| WO (1) | WO1997005134A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2788771B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique |
| FR2788775B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique |
| AU4314700A (en) * | 1999-04-28 | 2000-11-17 | Banyu Pharmaceutical Co., Ltd. | Processes for the preparation of piperidylmethylpyridine derivatives |
| FR3001151B1 (fr) | 2013-01-21 | 2016-04-08 | Pf Medicament | Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant |
| CN114349745B (zh) * | 2022-01-14 | 2023-12-08 | 黑龙江中医药大学 | 一种用于治疗心肌缺血的药物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
-
1995
- 1995-07-26 FR FR9509079A patent/FR2737207B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-25 DE DE69615696T patent/DE69615696T2/de not_active Expired - Fee Related
- 1996-07-25 DK DK96927083T patent/DK0842174T3/da active
- 1996-07-25 CA CA002228691A patent/CA2228691A1/fr not_active Abandoned
- 1996-07-25 WO PCT/FR1996/001176 patent/WO1997005134A1/fr not_active Application Discontinuation
- 1996-07-25 AU AU67031/96A patent/AU707950B2/en not_active Ceased
- 1996-07-25 AT AT96927083T patent/ATE206423T1/de not_active IP Right Cessation
- 1996-07-25 NZ NZ315347A patent/NZ315347A/xx unknown
- 1996-07-25 EP EP96927083A patent/EP0842174B1/fr not_active Expired - Lifetime
- 1996-07-25 CN CN96196566A patent/CN1103338C/zh not_active Expired - Fee Related
- 1996-07-25 ES ES96927083T patent/ES2165514T3/es not_active Expired - Lifetime
- 1996-07-25 JP JP9507283A patent/JPH11509857A/ja active Pending
- 1996-07-25 BR BR9609911A patent/BR9609911A/pt not_active IP Right Cessation
- 1996-07-25 US US09/011,207 patent/US6011032A/en not_active Expired - Fee Related
- 1996-07-25 PT PT96927083T patent/PT842174E/pt unknown
- 1996-07-25 KR KR1019980700648A patent/KR19990035986A/ko not_active Application Discontinuation
-
1998
- 1998-01-23 MX MX9800705A patent/MX9800705A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN1103338C (zh) | 2003-03-19 |
| CA2228691A1 (fr) | 1997-02-13 |
| DE69615696T2 (de) | 2002-07-11 |
| US6011032A (en) | 2000-01-04 |
| FR2737207A1 (fr) | 1997-01-31 |
| ATE206423T1 (de) | 2001-10-15 |
| AU707950B2 (en) | 1999-07-22 |
| NZ315347A (en) | 2000-01-28 |
| PT842174E (pt) | 2002-03-28 |
| DE69615696D1 (de) | 2001-11-08 |
| MX9800705A (es) | 1998-10-31 |
| ES2165514T3 (es) | 2002-03-16 |
| CN1193972A (zh) | 1998-09-23 |
| KR19990035986A (ko) | 1999-05-25 |
| EP0842174B1 (fr) | 2001-10-04 |
| JPH11509857A (ja) | 1999-08-31 |
| WO1997005134A1 (fr) | 1997-02-13 |
| DK0842174T3 (da) | 2002-01-28 |
| FR2737207B1 (fr) | 1997-10-17 |
| EP0842174A1 (fr) | 1998-05-20 |
| AU6703196A (en) | 1997-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20011067A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas | |
| YU49122B (sh) | Supstituisana benzilaminopiperidinska jedinjenja | |
| ZA842185B (en) | New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof | |
| ES2147399T3 (es) | Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica. | |
| MY122255A (en) | Acrylonitrile compounds, process for their production and pesticides containing them | |
| ES2177058T3 (es) | Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p. | |
| NO20003398L (no) | Substituerte 2-benzylamino-2-fenyl-acetamid-forbindelser | |
| BR9609911A (pt) | Compostos sendo novas n-heterociclil-1-ariloxialquil-4-piperdinaminas processo de preparação de compostos químicos e composições farmacêuticas | |
| DE69719511T2 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
| ATE184593T1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
| BR0114681A (pt) | Processos para o isolamento ou purificação de pravastatina ou um sal farmacologicamente aceitável da mesma e para o isolamento ou purificação de pravastatina sódio, e, composição compreendendo pravastatina sódio | |
| BR0114258A (pt) | Esteróides de 17alfa-fluoroalquila, processo para sua produção e composições farmacêuticas que contêm estes compostos | |
| DE69711920D1 (de) | Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale | |
| ATE464294T1 (de) | Verfahren zur herstellung eines chinolincarbaldehyds | |
| PT100682A (pt) | Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao | |
| BR0007675A (pt) | Novas 1,2-alcoil-1-[aril(alcoil)oxialcoil]pireridin-4-il]-3-aril isotiouréias susbtituìdas, processo de preparação dos compostos, medicamentos novos, e, composição farmacêutica | |
| ES2145905T3 (es) | Procedimiento de produccion de acido 3-isoxazolcarboxilico. | |
| DK0778839T3 (da) | Nye phosphanoxider, fremgangsmåde til deres fremstilling såvel som lægemidler indeholdende disse forbindelser | |
| PT971899E (pt) | Compostos de hexa-hidroindenopiridina possuindo actividade antiespermatogenica. | |
| GR3036896T3 (en) | A novel asymmetric synthesis of r and s warfarin and its analogs | |
| DE69610331T2 (de) | Neue gylcylanilid-derivate, deren herstellung und deren verwendung zur behandlung von hypercholesterolämie und atherosklerose | |
| PT1056769E (pt) | 15-metil-ciclopropanoesteroides e processo para a sua preparacao | |
| TH21054A (th) | อนุพันธ์ซัลโพแนมีดของแอโซโลน | |
| MX9304444A (es) | Nuevos derivados de acido piridinecarboxilico, proceso para preparar los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
| FF | Decision: intention to grant | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
| B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 13A, 14A, 15A, 16A, 17A, 18A, 19A E 20A ANUIDADES. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |